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Abstract
A strategy for photochemical cleavage of peptide and protein backbones is described, which is based
on a selenide-mediated cleavage of a backbone ester moiety. Studies in model systems establish the
viability of the chemistry and suggest the method could be a valuable tool for chemical biology
studies of proteins.
We describe here a new strategy for photochemical cleavage of peptide and protein backbones
and model studies intended to evaluate the viability of the novel chemistry involved. Strategies
for preparing photoresponsive biomolecules are finding increasing use in chemical biology.1,
2 Some time ago we introduced a strategy for photochemically initiating backbone cleavage
of a protein, employing the unnatural amino acid 2-nitrophenylglycine (Npg, Figure 1).3 After
incorporation of Npg into a protein or peptide, the well known o-nitrobenzyl “deprotection”
of the peptide bond nitrogen results in cleavage of the protein backbone, a site-specific,
nitrobenzyl-induced, photochemical proteolysis (SNIPP). Other strategies for photochemical
cleavage of protein and peptide backbones have recently appeared. Imperiali and Kron have
both employed o-nitro-β-phenylalanine as a linker between two protein or peptide fragments,
4,5 while Muir has employed an expanded nitrobenzyl linker.6 Otaka and coworkers introduced
a novel system based on a nitrobenzyl-caged phenol and the “trimethyl lock” motif, which
promoted intramolecular cleavage of the backbone amide after the phenol was decaged.7
Schultz and coworkers demonstrated a novel cleavage mediated by 2-nitrophenylalanine.8
All of these strategies have advantages and disadvantages. The Npg approach has been
employed in several contexts3,9,10 and is compatible with both solid phase peptide synthesis
(SPPS) and in vivo incorporation into full proteins via nonsense suppression. However, the
photochemical efficiency of the cleavage is not high, with a ~50% cleavage yield after four
hours of photolysis.3 Also, the incorporation into proteins of the relatively crowded, β-branched
residue is often not efficient. Similarly low photoefficiency is seen with 2-nitrophenylalanine.
8 The other strategies can show more efficient cleavage of peptides but are not compatible with
in vivo incorporation into proteins.
We envisioned an alternative strategy in which the key cleavage reaction is based on a novel,
intramolecular SN2 reaction, shown schematically in Figure 1. Selenide is one of the most
potent nucleophiles known, and at physiological pH a selenol (pKa ~5–6) should be
predominantly in the selenide form. The essential reaction, SN2 cleavage of an ester carbon
with a carboxylate as the leaving group, has ample precedent.11–15 Formation of the ester
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leaving group requires incorporation of an α-hydroxy acid (rather than an α-amino acid), but
such backbone esters can be efficiently incorporated into peptides by SPPS16,17 and into
proteins by nonsense suppression.10,18–22 In addition, selenium-containing natural amino
acids such as selenocysteine and selenomethionine are well known to be efficiently
incorporated into proteins. Finally, “caging” the selenide with an o-nitrobenzyl group allows
the process to be initiated photochemically.
The process proposed in Figure 1, however, raises many questions. Like all SN2 reactions, the
selenide-induced ester displacement is sensitive to steric effects. As such, the reaction is
typically applied to methyl esters, although under optimal conditions and with heating, ethyl,
benzyl, and even isopropyl esters along with many lactones are reactive. Certainly, the α -
carbon of the α-hydroxy acid that is incorporated will be sterically crowded. The question is
whether the intramolecularity of the process, perhaps aided by the inductive effect of the
neighboring amide carbonyl, will overcome the steric burden. Caged selenides are not
common, and so there is the question of the efficiency of the photochemical step. In addition,
selenides are sensitive to oxidation, more so for aliphatic than aromatic (selenophenol)
derivatives. On the other hand, an aliphatic selenide might be expected to be the stronger
nucleophile, but an aryl selenide has fewer rotatable bonds that need to be restricted in the
cyclization reaction.
Given these chemical uncertainties, it seemed prudent to first evaluate the viability of the
chemistry proposed in Figure 1 before proceeding with chemical biology studies. In the present
work we evaluate two structures that are meant to provide such a test. We describe the synthesis
and characterization of aliphatic (1) and aromatic (2) variants of the design, along with
mechanistic characterization.
Synthesis of enantiopure 1 (Scheme 1) began with conversion of S-(−)-tetrahydro-2-furoic acid
to the ring-opened bromide 4 as previously described.23,24 Conversion to the diselenide, and
ester hydrolysis then produced 6.25,26 Acid diselenide 6 was directly reduced with sodium
borohydride and the product alkylated with o-nitrobenzyl bromide to give the target compound
1.27
The synthesis of 2 (Scheme 2) began with the known reduction o f 2-nitrophenylpyruvic acid
by (+)-B-chlorodiisopinocampheylborane (“Ipc2BCl”) to yield 7 in 94% ee.28 The
selenocyanate was prepared by a modification of the standard sequence, and the nitrobenzyl
group was introduced by reductive alkylation. The bulky t-butyl protecting groups were
installed to discourage intramolecular cyclization, which was seen when 7 was subjected to
reducing conditions, as well as to improve the solubility and ease of purification of subsequent
compounds in the sequence.
To evaluate whether the proposed cleavage mechanism was viable, studies in model systems
were performed. Depsipeptides 12 and 14 were chosen for synthetic accessibility and because
they introduce a UV chromophore into the carboxylate cleavage product. They were prepared
through standard solution-phase coupling procedures, employing PyBop/N-methylmorpholine
and DCC/DMAP for the hydroxy-peptide- and depsipeptide-forming reactions, respectively.
Mass spectrometric analysis of initial photolysis studies indicated the formation of the
mechanistically revealing selenacyclopentane (13, 15) and the appropriate carboxylic acid, but
also suggested several complicating side reactions. Both 12 and 14 produced product m/z ratios
consistent with the dimer of the deprotected selenide, including the characteristic isotope
pattern for a structure with two selenium atoms. In addition, the aliphatic variant 12 showed
m/z ratios consistent with a depsipeptide containing dehydronorvaline (i.e., an allyl side chain),
presumably formed by elimination of the selenoxide produced by air oxidation. These
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undesirable reactions could be suppressed by running the photolyses in the presence of excess
dithiothreitol (DTT),29 which was expected to discourage both dimerization and oxidation.
For aryl selenide 14 an unanticipated side product, identified by mass spectrometry, was the
depsipeptide in which the original nitrobenzylselenyl group had been replaced by a hydrogen
atom. While this work was in progress, Kitahara and coworkers reported that short wavelength
photolysis of arylalkyl selenides can lead to C-Se bond cleavage.30 As suggested by that study,
we find that changing the photolysis wavelength from >300 nm (pyrex filter) to >330 nm
(uranium glass filter) eliminated this side reaction.
Of course, the novel process of Scheme 1 cannot be considered validated without unambiguous
confirmation that the selenacyclopentanes 13 and 15 were formed. Using the knowledge gained
from the preliminary studies, preparative-scale photolyses were performed (Scheme 3). For
both depsipeptides the selenacyclopentane product could be isolated after irradiation, providing
clear support for the proposed scheme; mass spectrometry and NMR spectroscopy confirm
product identities. We find that cleavage is more efficient with the aryl selenide (14) than the
alkyl (12), in that isolated yields of the selenacyclopentane are consistently higher (72% vs.
29%). In addition, obtaining significant yields of the selenacyclopentane from the aliphatic
system (12) required heating the photolysis mixture to ~70 °C, which was not necessary in the
case of aryl selenide 14 under optimal photolysis conditions. These observations, coupled with
the lack of complications due to olefin formation, suggest that aryl selenide 2 may be the better
system to incorporate for subsequent protein and peptide studies.
In summary, we describe novel chemistry in which a photochemically-liberated selenide
undergoes an intramolecular SN2 reaction, cleaving an ester that results from the incorporation
of the α-hydroxy acids 1 or 2 into a peptide. These studies suggest that for chemical biology
applications, aryl selenide 2 is the preferred substrate. Two side reactions have been discovered
that must be considered in possible chemical biology applications: dimerization and oxidation.
For studies involving peptides prepared by SPPS, adding DTT and controlling the
concentration might be appropriate. For in vivo nonsense suppression expression experiments,
where protein concentrations are typically low, dimerization may be less likely. In addition,
the reducing conditions inside cells likely will discourage dimerization and oxidation. Future
studies will evaluate the use of 1 and 2 in full proteins expressed in living cells.
Experimental Section
Representative procedure for selenacyclopentane formation (13 or 15)
One equivalent of depsipeptide 12 (0.0722 g; 0.088 mmol) or 14 (0.0230 g; 0.0250 mmol) was
placed in a pyrex reaction vessel and dissolved in acetonitrile (125 mL). To this was added
dithiothreitol (100 or 10 eq for 12 and 14, respectively) and 125 mL of pH 8 water (with 20
mM phosphate buffer for 12). The resulting solution was stirred under N2 (g), and a 450 W
medium-pressure mercury-vapor UV immersion lamp, filtered with a glass absorption sleeve
and equipped with a water cooling jacket, was assembled and attached to the reaction vessel.
The progress of the reaction was followed by ESI-MS. Following photolysis, the reaction of
12 was heated to 70 °C for 3 hours. Following aqueous work-up, the crude product was purified
by flash column chromatography to afford the selenacyclopentane product. Yield of 13 was
29%.). Rf = 0.28 (33% EtOAC in hexanes); [α]24D = − 16.0° (c = 1, CHCl3); 1H NMR of 13
(500 MHz, CDCl3, 298 K) δ 7.08 (1H, d, J = 13.5 Hz), 4.44 (1H, dt, J = 13.5, 8 Hz), 4.08 (1H,
m), 3.15 (1H, m), 2.97 (1H, m), 2.37 (1.5H, m), 2.26 (1.5H, m), 2.14 (4H, m), 1.92 (1H, m),
1.47 (9H, s), 1.44 (9H, s); 13C NMR of 13 (125 MHz, CDCl3, 298 K) 172.3, 172.1, 170.8,
82.3, 80.7, 52.8, 45.4, 37.4, 32.4, 31.5, 28.1, 28.0, 27.5, 27.1. HRMS (TOF) of 13 m/z calc’d
for C18H31NO5Se [M+H]: 422.1446, found 422.1465. Yield of 15 was 72%. Rf = 0.59 (30%
EtOAC in hexanes); [α]24D = − 80.5° (c = 1, CHCl3); 1H NMR of 15 (300 MHz, CDCl3, 298
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K) δ 7.30 (1H, m), 7.20 (1H, m), 7.12 (2H, m), 7.29 (2H, m), 6.92 (1H, d, J = 7.41 Hz), 4.50
(1H, dd, J = 8.2, 5.2 Hz), 4.43 (1H, dd, J = 7.8, 4.7 Hz), 2.25 (2H, m), 2.15 (1H, m), 1.91 (1H,
m), 1.44 (9H, s), 1.41 (9H, s); 13C NMR of 15 (75 MHz, CDCl3, 298 K) δ 172.4, 171.4, 170.7,
141.7, 135.3, 128.0, 125.9, 125.7, 125.5, 82.6, 81.0, 53.1, 45.9, 41.7, 31.6, 29.9, 28.3, 28.1;
HRMS of 15 (ESI) m/z calc’d for C22H31NO5Se [M+H]: 470.1446, found 470.1469.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Npg and the second-generation SNIPP unnatural α-hydroxy acids, 1 and 2.
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Scheme 1.
Synthesis of selenide α-hydroxy acid 1.
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Scheme 2.
Synthesis of selenide α-hydroxy acid 2.
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Scheme 3.
Depsipeptide cleavage reactions. Conditions described in Supplemental Material.
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